{"disease":{"id":"peripheral-arterial-disease","name":"Peripheral arterial disease","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":8},"drugs":{"marketed":[{"drug_id":"xarelto","indication_name":"Peripheral arterial disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xarelto","company_name":"University Hospital, Montpellier","drug_phase":"marketed","molecular_target":"Suppressor of tumorigenicity 14 protein, Coagulation factor X, Coagulation factor X","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"rivaroxaban","indication_name":"Peripheral arterial disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xarelto","generic_name":"rivaroxaban","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Factor Xa (FXa)","drug_class":"Direct Factor Xa Inhibitor","quality_score":71,"revenue":null,"mechanism":"Selective FXa inhibitor that decreases thrombin generation without requiring cofactors."},{"drug_id":"naftidrofuryl","indication_name":"Chronic Occlusive Peripheral Arterial Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nafronyl","generic_name":"naftidrofuryl","company_name":"","drug_phase":"unknown","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"naftidrofuryl","quality_score":null,"revenue":null,"mechanism":"Nafronyl works by interacting with the 5-hydroxytryptamine receptor 2A to improve blood flow and reduce vascular resistance."},{"drug_id":"naftidrofuryl-oxalate","indication_name":"Chronic Occlusive Peripheral Arterial Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Praxilene","generic_name":"naftidrofuryl oxalate","company_name":"Merck Serono (originally Lipha)","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"5-HT2 receptor antagonist, Peripheral vasodilator","quality_score":31,"revenue":null,"mechanism":"A 5-HT2 receptor antagonist that improves peripheral blood flow and cellular metabolism by blocking serotonin-mediated vasoconstriction and enhancing aerobic metabolism in ischaemic tissues."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03987633","title":"EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Future Genetics Limited","has_results":false},{"nct_id":"NCT04496544","title":"Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel-coated Devices (SAFE-PAD Study)","phase":"","overall_status":"COMPLETED","enrollment_count":168553,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT00526474","title":"Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":26449,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT04054440","title":"Outpatient Office Based Endovascular Procedures","phase":"","overall_status":"COMPLETED","enrollment_count":26000,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT02748226","title":"Korean Vascular Intervention Society Multicenter Registry Study on Outcomes of Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA): (A Retrospective & Prospective Observational Study)","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT06206369","title":"Developing Trustworthy Artificial Intelligence (AI)-Driven Tools to Predict Vascular Disease Risk and Progression","phase":"","overall_status":"RECRUITING","enrollment_count":11000,"lead_sponsor_name":"Amsterdam UMC, location VUmc","has_results":false},{"nct_id":"NCT04647643","title":"Real-World Safety Analysis of Paclitaxel Devices Used for the Treatment of Peripheral Arterial Disease","phase":"","overall_status":"COMPLETED","enrollment_count":8000,"lead_sponsor_name":"Lahey Clinic","has_results":false},{"nct_id":"NCT06989216","title":"Multi-modal Quantitative Imaging of the Skin","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"HJN Sverige AB/Neko Health","has_results":false},{"nct_id":"NCT06976073","title":"Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure","phase":"","overall_status":"RECRUITING","enrollment_count":8000,"lead_sponsor_name":"HJN Sverige AB/Neko Health","has_results":false},{"nct_id":"NCT06505317","title":"Artificial Intelligence for Early Detection of Peripheral Artery Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7800,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05852197","title":"Effect of Anticoagulant Drug Intervention on Postoperative MALE and MACE in Patients With PAD","phase":"","overall_status":"UNKNOWN","enrollment_count":6000,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT06850207","title":"Effect of Anticoagulant and Antiplatelet Drug Intervention on Postoperative Major Adverse Events in Patients with PAD：Phase II","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Chengdu University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT06275113","title":"BRING-UP Prevention","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Heart Care Foundation","has_results":false},{"nct_id":"NCT03098290","title":"IDOMENEO - Is Treatment Reality in Vascular Medicine Evidence-based and Follows Guideline Recommendations? A Project for Quality Development Exemplified by Peripheral Arterial Disease (PAD)","phase":"","overall_status":"COMPLETED","enrollment_count":5608,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03395509","title":"The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":4500,"lead_sponsor_name":"Central Jutland Regional Hospital","has_results":false},{"nct_id":"NCT05515653","title":"Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3974,"lead_sponsor_name":"Hospital Alemão Oswaldo Cruz","has_results":false},{"nct_id":"NCT06541691","title":"Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Rajaie Cardiovascular Medical and Research Center","has_results":false},{"nct_id":"NCT04619927","title":"Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":2276,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT05232474","title":"Using KomPas+ in the Treatment of Patients With Intermittent Claudication","phase":"NA","overall_status":"COMPLETED","enrollment_count":2271,"lead_sponsor_name":"Radboud University Medical Center","has_results":false},{"nct_id":"NCT05999669","title":"Predictive Value of the Global Limb Anatomic Staging System (GLASS) in Patients With Critical Limb-threatening Ischemia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT05756491","title":"Outpatient Hospitalization of Unaccompanied Patients at Home for Endovascular Treatment of Peripheral Arterial Disease.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Fondation Hôpital Saint-Joseph","has_results":false},{"nct_id":"NCT03496948","title":"Telephone Health Coaching and Remote Exercise Monitoring for Peripheral Artery Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":1982,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT07142655","title":"An Observational Study to Learn More About the Safety of Rivaroxaban in Participants With Peripheral Arterial Disease Who Had Surgery to Improve Blood Flow to Their Legs","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05881421","title":"DISRUPT PAD III Observational Study","phase":"","overall_status":"COMPLETED","enrollment_count":1373,"lead_sponsor_name":"Shockwave Medical, Inc.","has_results":false},{"nct_id":"NCT06775028","title":"Integrated Approach in Frail Older People with Atrial Fibrillation","phase":"NA","overall_status":"RECRUITING","enrollment_count":1250,"lead_sponsor_name":"Heart Care Foundation","has_results":false},{"nct_id":"NCT04238546","title":"Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Nils Kucher","has_results":false},{"nct_id":"NCT02424383","title":"Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter","phase":"NA","overall_status":"COMPLETED","enrollment_count":1005,"lead_sponsor_name":"C. R. Bard","has_results":true},{"nct_id":"NCT05018949","title":"Evaluation of Post-Angioplasty Outcomes","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Singapore General Hospital","has_results":false},{"nct_id":"NCT03426293","title":"Measuring the ACT During Non-cardiac Arterial Procedures.","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Dijklander Ziekenhuis","has_results":false},{"nct_id":"NCT07082517","title":"Observational Study of Risk Factors for Peripheral Artery Disease in Bathroom Scale Withings Body Cardio Users","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Withings","has_results":false},{"nct_id":"NCT05552079","title":"PAD Awareness Study","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT04283565","title":"Cost-utility Analysis, Cost-effectiveness Analysis, Budget Impact Analysis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":960,"lead_sponsor_name":"University Hospital, Tours","has_results":false},{"nct_id":"NCT06253312","title":"Treatment of TASC C and D Aortoiliac Lesions","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Clinical Centre of Serbia","has_results":false},{"nct_id":"NCT04342481","title":"Education and Management of PAD in Primary Care","phase":"","overall_status":"COMPLETED","enrollment_count":891,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT05616520","title":"Treatment of Complex Femoropopliteal Artery Lesions Using Drug-coated PTA Balloon","phase":"","overall_status":"UNKNOWN","enrollment_count":838,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT03357367","title":"TiVi Evaluation of Microcirculatory Reactivity of the Skin to Galvanic Stimulation: Effect of Aspirin","phase":"NA","overall_status":"COMPLETED","enrollment_count":830,"lead_sponsor_name":"University Hospital, Angers","has_results":false},{"nct_id":"NCT05391815","title":"This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT04966767","title":"Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06980064","title":"Wearable Devices Assist in the Detection, Screening, and Management of Major Diseases in Middle-aged and Elderly Populations","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04560998","title":"A Research Study to Compare a Medicine Called Semaglutide Against Placebo in People With Peripheral Arterial Disease and Type 2 Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":792,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT06020534","title":"Aortoiliac Stenosis in Kidney Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":655,"lead_sponsor_name":"Erasmus Medical Center","has_results":true},{"nct_id":"NCT03378024","title":"Evaluate the Correlation of NIRS, ABI, Exercise, baPWV and Albuminuria With Peripheral Artery Occlusion Disease (PAD) and Other Atherosclerosis Outcomes","phase":"","overall_status":"UNKNOWN","enrollment_count":650,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT04753372","title":"Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk","phase":"","overall_status":"COMPLETED","enrollment_count":645,"lead_sponsor_name":"Maatschap Cardiologie Zwolle","has_results":false},{"nct_id":"NCT05009602","title":"Diagnostic Tools to Establish the Presence and Severity of Peripheral Arterial Disease in People With Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":604,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT06250790","title":"Selective Coronary Revascularization in Peripheral Artery Disease Patients (SCOREPAD Trial)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Pauls Stradins Clinical University Hospital","has_results":false},{"nct_id":"NCT07016698","title":"Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)","phase":"NA","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"C. R. Bard","has_results":false},{"nct_id":"NCT07023965","title":"Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":542,"lead_sponsor_name":"Beijing Northland Biotech. Co., Ltd.","has_results":false},{"nct_id":"NCT02475200","title":"Phoenix Post-Approval Registry - Using the Phoenix Atherectomy Systems","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Volcano Corporation","has_results":false},{"nct_id":"NCT05868161","title":"Pounce™ Thrombectomy System Retrospective Registry","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"SurModics, Inc.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}